Characteristics of postjunctional carbamylcholine receptor activation and inhibition
Johnson, E.W.; Parsons, R.L.
American Journal of Physiology 222(3): 793-799
1972
ISSN/ISBN: 0002-9513 PMID: 4537138 Document Number: 52048
Document emailed within 1 workday
Related Documents
Zhu, Z.; Rockwell, P.; Lu, D.; Kotanides, H.; Pytowski, B.; Hicklin, D.J.; Bohlen, P.; Witte, L. 1998: Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library Cancer Research 58(15): 3209-3214Guo, W.X.; Gill, P.S.; Antakly, T. 1995: Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation Cancer Research 55(4): 823-829
Panic, A.; Stanimirovic, J.; Obradovic, M.; Zafirovic, S.; Sudar-Milovanovic, E.; Petrovic, N.; Isenovic, E.R. 2018: 17β-estradiol inhibits hepatic iNOS via the activation of the estrogen receptor ER-α and inhibition of erk1/2-mir-221 axis Journal of Biological Regulators and Homeostatic Agents 32(6): 1369-1377
Yang, X.; Ferguson, A.T.; Nass, S.J.; Phillips, D.L.; Butash, K.A.; Wang, S.M.; Herman, J.G.; Davidson, N.E. 2000: Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition Cancer Research 60(24): 6890-6894
Tanguay, D.; Pavlovic, S.; Piatelli, M.J.; Bartek, J.; Chiles, T.C. 1999: B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors Journal of Immunology 163(6): 3160-3168
Fischman, C.M.; Udey, M.C.; Kurtz, M.; Wedner, H.J. 1981: Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence Journal of Immunology 127(6): 2257-2262
Ashman, R.F. 1990: B lymphocyte activation: the transferrin receptor as a prototype intermediate activation molecule Journal of Laboratory and Clinical Medicine 116(6): 759-765
Jamieson, G.A. 1988: The activation of platelets by thrombin: a model for activation by high and moderate affinity receptor pathways Progress in Clinical and Biological Research 283: 137-158
Heidaran, M.A.; Molloy, C.J.; Pangelinan, M.; Choudhury, G.G.; Wang, L.M.; Fleming, T.P.; Sakaguchi, A.Y.; Pierce, J.H. 1992: Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras Oncogene 7(1): 147-152
Siegel, J.N.; June, C.H.; Yamada, H.; Rapp, U.R.; Samelson, L.E. 1993: Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells Journal of Immunology 151(8): 4116-4127
Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Colamonici, O.R.; Ang, S.; Quinones, R.; Henkart, P.; Heikkila, R.; Gress, R.; Felix, C.; Kirsch, I.; Longo, D.; Marti, G. 1988: IL-2-dependent expansion of CD3+ large granular lymphocytes expressing T cell receptor-gamma delta. Evidence for a functional receptor by anti-CD3 activation of cytolysis Journal of Immunology 140(8): 2527-2533
van Vliet, B.J.; Mulder, A.H.; Schoffelmeer, A.N. 1990: Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons Progress in Clinical and Biological Research 328: 409-412
Cech, S.Y.; Maguire, M.E. 1982: Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation Molecular Pharmacology 22(2): 267-273
Dye, J.R.; Palvanov, A.; Guo, B.; Rothstein, T.L. 2007: B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation Journal of Immunology 179(1): 229-235
Echeverría, O.M.; Thampan, R.V.; Juárez-Chavero, S.; Hernández-Pérez, A.D.; Ortiz, R.; Vázquez-Nin, G.H. 2005: Immunocytochemical study of estrogen receptor activation factor (E-RAF) and the proteins that interact with nuclear estrogen receptor II (nER II) in epithelial endometrial cells, in the presence and in the absence of estradiol European Journal of Histochemistry: Ejh 49(1): 67-74
Eriks, J.C.; van der Goot, H.; Timmerman, H. 1993: New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists Molecular Pharmacology 44(4): 886-894
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302
Kim, S.O.; Park, J.G.; Lee, Y.I. 1996: Increased expression of the insulin-like growth factor i (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-i receptor gene activation by hepatitis B virus X gene product Cancer Research 56(16): 3831-3836
Kirchhof, B. 1984: Methodologic studies of the activation and inhibition of thrombin Fortschritte der Medizin 102(41): 1056-1058